Anthem Blue Cross and Blue Shield | CommercialJanuary 16, 2025
Asthma Medication Ratio (AMR) 2025
HEDIS® is a widely used set of performance measures developed and maintained by the National Committee for Quality Assurance (NCQA). These are used to drive improvement efforts surrounding best practices.
HEDIS measure
This HEDIS measure looks at the percentage of patients 5 to 64 years old who were identified as having persistent asthma and had a ratio of controller medications to total asthma medications of 0.50 or greater during the measurement year.
Refer to attachment to view full details
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Maine, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
MULTI-BCBS-CM-075668-24-CPN74724
ATTACHMENTS: Asthma Medication Ratio (AMR) 2025 - Blue Cross Blue Shield (pdf - 0.34mb)
To view this article online:
Visit https://providernews.anthem.com/maine/articles/asthma-medication-ratio-amr-2025-23735
Or scan this QR code with your phone